PL2081547T3 - Postać galenowa do podawania składników czynnych poprzez śluzówkę - Google Patents

Postać galenowa do podawania składników czynnych poprzez śluzówkę

Info

Publication number
PL2081547T3
PL2081547T3 PL07848363T PL07848363T PL2081547T3 PL 2081547 T3 PL2081547 T3 PL 2081547T3 PL 07848363 T PL07848363 T PL 07848363T PL 07848363 T PL07848363 T PL 07848363T PL 2081547 T3 PL2081547 T3 PL 2081547T3
Authority
PL
Poland
Prior art keywords
trans
active ingredients
mucosal delivery
galenic form
galenic
Prior art date
Application number
PL07848363T
Other languages
English (en)
Inventor
Philippe Perovitch
Marc Maury
Original Assignee
Philippe Perovitch
Marc Maury
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Philippe Perovitch, Marc Maury filed Critical Philippe Perovitch
Publication of PL2081547T3 publication Critical patent/PL2081547T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nutrition Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Physiology (AREA)
  • Endocrinology (AREA)
  • Pulmonology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL07848363T 2006-09-22 2007-09-21 Postać galenowa do podawania składników czynnych poprzez śluzówkę PL2081547T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0653899A FR2906140B1 (fr) 2006-09-22 2006-09-22 Forme galenique pour l'administration par voie trans-muqueuse de principes actifs
EP07848363A EP2081547B1 (fr) 2006-09-22 2007-09-21 Forme galenique pour l'administration par voie trans-muqueuse de principes actifs
PCT/FR2007/051993 WO2008035020A2 (fr) 2006-09-22 2007-09-21 Forme galenique pour l'administration par voie trans-muqueuse de principes actifs

Publications (1)

Publication Number Publication Date
PL2081547T3 true PL2081547T3 (pl) 2012-10-31

Family

ID=37806741

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07848363T PL2081547T3 (pl) 2006-09-22 2007-09-21 Postać galenowa do podawania składników czynnych poprzez śluzówkę

Country Status (12)

Country Link
US (1) US10758479B2 (pl)
EP (1) EP2081547B1 (pl)
JP (1) JP2010504312A (pl)
CN (1) CN101522167A (pl)
AU (1) AU2007298814B2 (pl)
BR (1) BRPI0715154A2 (pl)
CA (1) CA2663062C (pl)
ES (1) ES2386827T3 (pl)
FR (1) FR2906140B1 (pl)
MX (1) MX2009003030A (pl)
PL (1) PL2081547T3 (pl)
WO (1) WO2008035020A2 (pl)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2926721B1 (fr) 2008-01-30 2011-07-22 Philippe Perovitch Forme galenique pour l'adminsitration par voie trans-muqueuse de triptans
JP5410070B2 (ja) * 2008-10-07 2014-02-05 久光製薬株式会社 エステル化抑制剤としての炭酸金属塩及び炭酸金属塩によるエステル化抑制方法
FR2940120B1 (fr) * 2008-12-19 2012-07-13 Philippe Perovitch Formulation pour l'administration par voie trans-muqueuse de setrons
FR2940116B1 (fr) * 2008-12-22 2012-07-06 Philippe Perovitch Formulation pour l'administration d'hypolipemiant par voie trans-muqueuse buccale
FR2940911B1 (fr) * 2009-01-13 2012-09-21 Philippe Perovitch Formulation pour l'administration par voie trans-muqueuse buccale de molecules antalgiques et/ou anti-spasmodiques
JP5686978B2 (ja) * 2009-03-18 2015-03-18 第一三共ヘルスケア株式会社 シルデナフィルクエン酸塩含有内服液剤及びその液剤含有容器
US8263581B2 (en) 2009-07-03 2012-09-11 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof
US8513259B2 (en) 2009-07-03 2013-08-20 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof
FR2947729B1 (fr) 2009-07-10 2012-01-20 Philippe Perovitch Composition pharmaceutique pour le traitement du diabete de type ii par voie trans-muqueuse buccale
GB2497933B (en) * 2011-12-21 2014-12-24 Londonpharma Ltd Drug delivery technology
FR3000896B1 (fr) * 2013-01-14 2016-08-26 Philippe Perovitch Forme galenique pour l'administration de principe(s) actif(s) permettant l'induction acceleree du sommeil et/ou le traitement des troubles du sommeil
EP3082428A4 (en) 2013-12-09 2017-08-02 Respira Therapeutics, Inc. Pde5 inhibitor powder formulations and methods relating thereto
NO2723977T3 (pl) * 2014-03-19 2018-03-10
US9855234B2 (en) * 2014-07-08 2018-01-02 Insys Development Company, Inc. Diclofenac sublingual spray
FR3031668A1 (fr) * 2015-01-20 2016-07-22 Philippe Perovitch Dispositif d'administration d'un principe actif par voie per-muqueuse buccale.
JP6669513B2 (ja) * 2016-02-03 2020-03-18 富士ゼロックス株式会社 回路基板および回路基板の製造方法
FR3053244A1 (fr) 2016-07-01 2018-01-05 Philippe Perovitch Dispositif d'administration d'au moins un principe actif par voie per-muqueuse buccale.
US10744087B2 (en) 2018-03-22 2020-08-18 Incarda Therapeutics, Inc. Method to slow ventricular rate
US11020384B2 (en) 2019-08-01 2021-06-01 Incarda Therapeutics, Inc. Antiarrhythmic formulation

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3001403A (en) * 1957-07-01 1961-09-26 William R Kiser Jr Liquid sampler
FR2649611A1 (fr) * 1989-07-13 1991-01-18 Philippe Perovitch Procede de preparation galenique d'une composition therapeutique notamment a base d'aspirine
US5683721A (en) * 1990-07-26 1997-11-04 Perovitch; Philippe Galenic preparation of therapeutic composition comprising aspirin
HU214582B (hu) * 1994-07-26 1998-04-28 EGIS Gyógyszergyár Rt. Porlasztható, vérnyomáscsökkentő hatású gyógyszerkészítmény és eljárás előállítására
US20030077229A1 (en) * 1997-10-01 2003-04-24 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing cardiovascular or renal drugs
US20030077227A1 (en) * 1997-10-01 2003-04-24 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
US6221378B1 (en) * 1998-02-10 2001-04-24 Generex Pharmaceuticals Incorporated Mixed micellar delivery system and method of preparation
US20020086878A1 (en) * 1999-01-11 2002-07-04 Douglas Joseph Dobrozsi Compositions having improved stability
WO2002074238A2 (en) * 2001-02-16 2002-09-26 Lavipharm Laboratories Inc. Water soluble and palatable complexes
SE0104388D0 (sv) * 2001-12-27 2001-12-27 Pharmacia Ab New formulation and use and manufacture thereof
GB2392093B (en) * 2002-08-14 2006-03-08 Gw Pharma Ltd Pharmaceutical formulations
CA2597956C (en) * 2005-02-17 2013-07-09 Velcera Pharmaceuticals Transmucosal administration of drug compositions for treating and preventing disorders in animals
DE102005009240A1 (de) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit verbesserten pharmakokinetischen Eigenschaften
FR2910317B1 (fr) * 2006-12-21 2009-02-13 Philippe Perovitch Forme galenique pour l'administration par voie transmuqueuse de paracetamol
FR2940116B1 (fr) * 2008-12-22 2012-07-06 Philippe Perovitch Formulation pour l'administration d'hypolipemiant par voie trans-muqueuse buccale

Also Published As

Publication number Publication date
US20100022496A1 (en) 2010-01-28
FR2906140A1 (fr) 2008-03-28
JP2010504312A (ja) 2010-02-12
US10758479B2 (en) 2020-09-01
BRPI0715154A2 (pt) 2013-06-04
CN101522167A (zh) 2009-09-02
ES2386827T3 (es) 2012-08-31
WO2008035020A3 (fr) 2009-02-12
CA2663062A1 (fr) 2008-03-27
MX2009003030A (es) 2009-05-08
FR2906140B1 (fr) 2008-12-05
AU2007298814A1 (en) 2008-03-27
WO2008035020A2 (fr) 2008-03-27
CA2663062C (fr) 2016-09-13
AU2007298814B2 (en) 2013-10-24
EP2081547A2 (fr) 2009-07-29
EP2081547B1 (fr) 2012-05-23

Similar Documents

Publication Publication Date Title
PL2081547T3 (pl) Postać galenowa do podawania składników czynnych poprzez śluzówkę
HK1140139A1 (en) Multistage delivery of active agents
EP2078731A4 (en) PHARMACEUTICAL COMPOSITION COMPRISING ANTI-HB-EGF ANTIBODY AS ACTIVE INGREDIENT
EP2130552A4 (en) PHARMACEUTICAL COMPOSITION COMPRISING AN ANTI-GRP78 ANTIBODY AS AN ACTIVE SUBSTANCE
EP2012751A4 (en) NEW NANOPARTICLES FOR THE DELIVERY OF ACTIVE AGENTS
PL1981915T3 (pl) Kompozycje składników aktywnych
HK1127877A1 (en) Composition containing peptide as the active ingredient
ZA200809864B (en) Pharmaceutical formulations for the sustained release of active ingredients(s), as well as their applications, especially therapeutic
HK1182010A1 (en) Liquid pharmaceutical composition for the delivery of active ingredients
SI3984528T1 (sl) Farmacevtski sestavki, ki vsebujejo nilotinib
EP2081550A4 (en) COATING CAPSULES WITH ACTIVE PHARMACEUTICAL INGREDIENTS
HK1143731A1 (zh) 利培酮類化合物的緩釋製劑
EP2054339A4 (en) PARTICULARS FOR ACTIVE INHIBITION, MANUFACTURING METHOD AND COMPOSITIONS THEREOF
HK1142536A1 (en) Gel useful for the delivery of cosmetic active ingredients
ZA200710734B (en) Compositions for drug delivery
IL199362A (en) Pyridopyrimidine Compounds, Pharmaceuticals, Compounds for Use as a Drug, and Compounds for Manufacture @ Drug
EP2220081A4 (en) GLUCCOAINEACTIVATORS AND THESE PHARMACEUTICAL COMPOSITIONS CONTAINING ACTIVE SUBSTANCES
IL222578A0 (en) Method for preparing pharmaceutical compositions intended for oral administration comprising one or more active ingredients and the compositions comprising same
EP2112925A4 (en) SOLID PHARMACEUTICAL DOSAGE FORMULATIONS
EP2023974A4 (en) RELEASE OF MULTICOMPONENT COMPOSITIONS
ZA200807486B (en) Medicament formulations comprising fluoroquinolones
SG138567A1 (en) Punctal plugs for the delivery of active agents
SG138565A1 (en) Punctal plugs for the delivery of active agents
WO2011002422A3 (en) Solubility enhancing pharmaceutical formulation
WO2008003050A3 (en) Gallium nitrate formulations